Designer baby, anyone? A New Jersey startup company, Genomic Prediction, might be able to help you.
Genomic Prediction claims to be able to use DNA testing to predict disease risk in an embryo. The idea is to study hundreds or thousands of small variations in DNA, known as genetic markers, and use sophisticated computer algorithms to correlate these with diseases such as type 1 and type 2 diabetes, breast cancer and “intellectual disability”.
If the company’s recent research is any guide, it may move on to predicting other traits such as height and even educational attainment.
But the connections between genetic variations and differences in real human beings are far from straightforward. And even if we can make these connections, should we?
Read the full story in The Conversation: An American company will test your embryos for genetic defects. But designer babies aren’t here just yet